Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
The present disclosure is directed to a pharmaceutical formulation intended for oral delivery of synthetic or natural poorly permeable calcitonin gene-related peptide (CGRP) inhibitors or salts/solvates thereof having a therapeutic activity. The pharmaceutical formulation can include a synthetic or...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PLASSAT, Vincent POINTEAUX, Thomas CONWAY, Charles M MEISSONNIER, Julien DUBOWCHIK, Gene M GALUS, Aurélia HILBOLD, Benoit |
description | The present disclosure is directed to a pharmaceutical formulation intended for oral delivery of synthetic or natural poorly permeable calcitonin gene-related peptide (CGRP) inhibitors or salts/solvates thereof having a therapeutic activity. The pharmaceutical formulation can include a synthetic or natural poorly permeable CGRP inhibitors or salt or solvate thereof in an amount 0.01-10 wt.% of the total weight of the formulation; a lipophilic phase comprising triglycerides of fatty acids in an amount of 50-80 wt.% of the total weight of the formulation; and at least one lipophilic surfactant comprising partial esters of polyol and fatty acids in an amount of about 10-50 wt.% of the total weight of the formulation. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020270985A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020270985A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020270985A13</originalsourceid><addsrcrecordid>eNqNjEEKwkAMRbtxIeodAm4VqiLqsojFA-jWEtsUA5lJmJkqvb2z8ADyFw8ejz8tHrUGNwgmVg-9BtCAAh0JvymMoD1Y0ETs4wqMLHFHEdB3EB2KgFOhdpDsPpxeYJofjIIjfLJwGufFpEeJtPhxVizry-18XZNpQ9GwJU-pqe7bMu9Qno77arP7r_oCbOE97w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Formulation for oral delivery of proteins, peptides and small molecules with poor permeability</title><source>esp@cenet</source><creator>PLASSAT, Vincent ; POINTEAUX, Thomas ; CONWAY, Charles M ; MEISSONNIER, Julien ; DUBOWCHIK, Gene M ; GALUS, Aurélia ; HILBOLD, Benoit</creator><creatorcontrib>PLASSAT, Vincent ; POINTEAUX, Thomas ; CONWAY, Charles M ; MEISSONNIER, Julien ; DUBOWCHIK, Gene M ; GALUS, Aurélia ; HILBOLD, Benoit</creatorcontrib><description>The present disclosure is directed to a pharmaceutical formulation intended for oral delivery of synthetic or natural poorly permeable calcitonin gene-related peptide (CGRP) inhibitors or salts/solvates thereof having a therapeutic activity. The pharmaceutical formulation can include a synthetic or natural poorly permeable CGRP inhibitors or salt or solvate thereof in an amount 0.01-10 wt.% of the total weight of the formulation; a lipophilic phase comprising triglycerides of fatty acids in an amount of 50-80 wt.% of the total weight of the formulation; and at least one lipophilic surfactant comprising partial esters of polyol and fatty acids in an amount of about 10-50 wt.% of the total weight of the formulation.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211209&DB=EPODOC&CC=AU&NR=2020270985A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211209&DB=EPODOC&CC=AU&NR=2020270985A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PLASSAT, Vincent</creatorcontrib><creatorcontrib>POINTEAUX, Thomas</creatorcontrib><creatorcontrib>CONWAY, Charles M</creatorcontrib><creatorcontrib>MEISSONNIER, Julien</creatorcontrib><creatorcontrib>DUBOWCHIK, Gene M</creatorcontrib><creatorcontrib>GALUS, Aurélia</creatorcontrib><creatorcontrib>HILBOLD, Benoit</creatorcontrib><title>Formulation for oral delivery of proteins, peptides and small molecules with poor permeability</title><description>The present disclosure is directed to a pharmaceutical formulation intended for oral delivery of synthetic or natural poorly permeable calcitonin gene-related peptide (CGRP) inhibitors or salts/solvates thereof having a therapeutic activity. The pharmaceutical formulation can include a synthetic or natural poorly permeable CGRP inhibitors or salt or solvate thereof in an amount 0.01-10 wt.% of the total weight of the formulation; a lipophilic phase comprising triglycerides of fatty acids in an amount of 50-80 wt.% of the total weight of the formulation; and at least one lipophilic surfactant comprising partial esters of polyol and fatty acids in an amount of about 10-50 wt.% of the total weight of the formulation.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwkAMRbtxIeodAm4VqiLqsojFA-jWEtsUA5lJmJkqvb2z8ADyFw8ejz8tHrUGNwgmVg-9BtCAAh0JvymMoD1Y0ETs4wqMLHFHEdB3EB2KgFOhdpDsPpxeYJofjIIjfLJwGufFpEeJtPhxVizry-18XZNpQ9GwJU-pqe7bMu9Qno77arP7r_oCbOE97w</recordid><startdate>20211209</startdate><enddate>20211209</enddate><creator>PLASSAT, Vincent</creator><creator>POINTEAUX, Thomas</creator><creator>CONWAY, Charles M</creator><creator>MEISSONNIER, Julien</creator><creator>DUBOWCHIK, Gene M</creator><creator>GALUS, Aurélia</creator><creator>HILBOLD, Benoit</creator><scope>EVB</scope></search><sort><creationdate>20211209</creationdate><title>Formulation for oral delivery of proteins, peptides and small molecules with poor permeability</title><author>PLASSAT, Vincent ; POINTEAUX, Thomas ; CONWAY, Charles M ; MEISSONNIER, Julien ; DUBOWCHIK, Gene M ; GALUS, Aurélia ; HILBOLD, Benoit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020270985A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PLASSAT, Vincent</creatorcontrib><creatorcontrib>POINTEAUX, Thomas</creatorcontrib><creatorcontrib>CONWAY, Charles M</creatorcontrib><creatorcontrib>MEISSONNIER, Julien</creatorcontrib><creatorcontrib>DUBOWCHIK, Gene M</creatorcontrib><creatorcontrib>GALUS, Aurélia</creatorcontrib><creatorcontrib>HILBOLD, Benoit</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PLASSAT, Vincent</au><au>POINTEAUX, Thomas</au><au>CONWAY, Charles M</au><au>MEISSONNIER, Julien</au><au>DUBOWCHIK, Gene M</au><au>GALUS, Aurélia</au><au>HILBOLD, Benoit</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Formulation for oral delivery of proteins, peptides and small molecules with poor permeability</title><date>2021-12-09</date><risdate>2021</risdate><abstract>The present disclosure is directed to a pharmaceutical formulation intended for oral delivery of synthetic or natural poorly permeable calcitonin gene-related peptide (CGRP) inhibitors or salts/solvates thereof having a therapeutic activity. The pharmaceutical formulation can include a synthetic or natural poorly permeable CGRP inhibitors or salt or solvate thereof in an amount 0.01-10 wt.% of the total weight of the formulation; a lipophilic phase comprising triglycerides of fatty acids in an amount of 50-80 wt.% of the total weight of the formulation; and at least one lipophilic surfactant comprising partial esters of polyol and fatty acids in an amount of about 10-50 wt.% of the total weight of the formulation.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2020270985A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Formulation for oral delivery of proteins, peptides and small molecules with poor permeability |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T11%3A55%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PLASSAT,%20Vincent&rft.date=2021-12-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020270985A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |